Adult Immunisation Advisor

Based on API Consensus Guidelines (2026), WHO & ACIP Recommendations

1. Age Group

2. Biological Sex

3. Pregnant or Planning Pregnancy? ?

4. Comorbidities & Risk Factors ?

◆ Evidence-Based Pearls & Pathophysiology

1. Malpractice Warning: The Tetanus Toxoid (TT) Trap

⚠ Avoid Standalone TT: In India, there is a widespread malpractice of prescribing standalone Tetanus Toxoid (TT) for wound management or during pregnancy. Pathophysiology/Epidemiology: Due to waning adult immunity against Diphtheria (which relies on herd immunity), the Government of India officially replaced TT with Td (Tetanus & adult-dose Diphtheria) in the National Immunisation Schedule in 2019. You MUST prescribe Td or Tdap, never standalone TT.

2. Illness Script: Identifying Live Vaccines (Mnemonic)

Live attenuated vaccines carry a risk of uncontrolled viral or bacterial replication. They are strictly contraindicated in pregnant women (due to teratogenicity as pathogens cross the placenta) and severely immunocompromised patients.

💡 Mnemonic: "Be A VIP, MMR!"
BCG
Adenovirus (oral)
Varicella
Influenza (LAIV - Intranasal only)
Polio (OPV - Oral)
Measles, Mumps, Rubella (MMR)
*Also includes Yellow Fever and Zoster (ZVL/Zostavax).

3. Why Adult Immunisation Matters in India

  • Immunosenescence: Age-related decline in innate and adaptive immune function increases susceptibility and mortality to influenza, pneumococcal disease, and herpes zoster in older adults.
  • Comorbidity Burden: India's rising prevalence of diabetes, CKD, and COPD creates massive cohorts of patients whose baseline mucosal immunity is impaired, requiring targeted vaccination.
  • AMR Stewardship: Viral vaccines (like Influenza) prevent secondary bacterial pneumonias, directly reducing unnecessary empirical broad-spectrum antibiotic prescriptions.

4. Pneumococcal Strategy: The PCV20 Shift

⚠ Avoid Simultaneous Administration Malpractice: Never give PCV and PPSV23 at the same time. Simultaneous administration induces B-cell immune tolerance and blunts the antibody response.

API 2026 Shift: PCV20 is now the preferred single-dose pneumococcal vaccine. It covers 7 additional serotypes compared to PCV13, eliminating the need for the older, sequential PCV13 → (wait 1 year) → PPSV23 approach, which suffered from high drop-out rates and polysaccharide-induced hyporesponsiveness.

5. Herpes Zoster (Shingles) Vaccination

Vaccine Type Pathophysiology & Recommendation
RZV (Shingrix)
Recommended		 Recombinant glycoprotein E antigen with AS01B adjuvant. Non-live. Highly immunogenic. Safe in immunocompromised patients. Recommended for ALL adults ≥50 years, and immunocompromised ≥18 years.
ZVL (Zostavax)
Obsolete		 Live-attenuated virus. Contraindicated in immunosuppression. Waning efficacy. No longer recommended by API or CDC.

6. Vaccination in Pregnancy

The goal is dual protection: protecting the mother from severe disease (e.g., Influenza) and providing passive transplacental IgG antibodies to the neonate (e.g., Pertussis).

Status Vaccines
✓ STRONGLY RECOMMENDED Tdap: 27-36 weeks, in EACH pregnancy to maximise transplacental pertussis antibodies.
Inactivated Influenza: Any trimester.
⚠ USE IF INDICATED Hepatitis B (if at risk and unvaccinated); Pneumococcal.
✗ CONTRAINDICATED Live Vaccines (MMR, Varicella, LAIV, BCG, Yellow Fever). Wait at least 4 weeks after a live vaccine before conceiving. HPV is also deferred.
Abbreviations: API (Association of Physicians of India) · Td (Tetanus & adult Diphtheria) · Tdap (Tetanus, Diphtheria & acellular Pertussis) · IIV (Inactivated Influenza Vaccine) · LAIV (Live Attenuated Influenza Vaccine) · PCV (Pneumococcal Conjugate Vaccine) · PPSV23 (Pneumococcal Polysaccharide Vaccine) · RZV (Recombinant Zoster Vaccine) · ZVL (Zoster Vaccine Live) · HPV (Human Papillomavirus) · MMR (Measles, Mumps, Rubella) · HepA/B (Hepatitis A/B) · HCW (Healthcare Worker) · CKD (Chronic Kidney Disease) · CLD (Chronic Liver Disease) · COPD (Chronic Obstructive Pulmonary Disease) · CHF (Congestive Heart Failure) · DM (Diabetes Mellitus) · NIS (National Immunisation Schedule)
Algorithm References & Evidence Base
  1. Association of Physicians of India (API). Indian Consensus Guidelines on Adult Immunization, 2026 Update. API; 2026.
  2. Dhawan AM, Desai A, Gvalani A, Anand S, Das P. A comprehensive review of the latest Indian guidelines on adult immunization. Int J Community Med Public Health. 2025;12(2):1159-1165.
  3. Centers for Disease Control and Prevention (CDC). Adult Immunization Schedule by Age. ACIP; Updated 2026.
  4. Giriappa B, Choraria N, Ponce P, et al. Immunogenicity and safety of 20-valent PCV (PCV20) in adults ≥18 y of age in India. Hum Vaccin Immunother. 2026;22(1):2605847.
  5. World Health Organization. WHO Recommendations for Routine Immunization: Summary Tables. Geneva: WHO; 2023.
How to Cite This Tool

AMA Style:
Umakanth S. Adult Immunisation Advisor. MEDiscuss. Published 2026. Accessed .

Vancouver Style:
Umakanth S. Adult Immunisation Advisor [Internet]. MEDiscuss.org; 2026 [cited ]. Available from:

⚠ Disclaimer: This decision-support system is intended for healthcare professionals. It does not substitute clinical judgment. These algorithms are evidence-based, but medical knowledge evolves continuously. The treating physician retains absolute responsibility for all diagnostic, dosing, and therapeutic decisions. Always verify outputs against current institutional protocols and individual patient contexts.
© 2026 MEDiscuss.org. All rights reserved. This CDSS Module was conceptualised, designed and developed by
Dr. Shashikiran Umakanth.Provided free of charge for clinical use. Unauthorised reproduction or redistribution is strictly prohibited.
Related Clinical Tools
Hepatitis B Needlestick PEP AdvisorPediatric Immunization AdvisorTetanus Wound Prophylaxis Advisor
Back to All Medical Calculators & Pathways